{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:18:28Z","timestamp":1788668308797,"version":"build-2803163510"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T00:00:00Z","timestamp":1701993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Basic Research Plan Project of Yunnan Provincial Science and Technology Department","award":["H-2019053"],"award-info":[{"award-number":["H-2019053"]}]},{"name":"Basic Research Plan Project of Yunnan Provincial Science and Technology Department","award":["202001AY070001-028"],"award-info":[{"award-number":["202001AY070001-028"]}]},{"name":"Clinical Medical Center for Cardiovascular and Cerebrovascular Disease of Yunnan Province","award":["ZX2019-03-01"],"award-info":[{"award-number":["ZX2019-03-01"]}]},{"name":"Clinical Medical Center for Cardiovascular and Cerebrovascular Disease of Yunnan Province","award":["ZX2019-03-01"],"award-info":[{"award-number":["ZX2019-03-01"]}]},{"name":"Clinical Medical Center for Cardiovascular and Cerebrovascular Disease of Yunnan Province","award":["ZX2019-03-01"],"award-info":[{"award-number":["ZX2019-03-01"]}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82160439"],"award-info":[{"award-number":["82160439"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Yunnan Provincial Training Project of High-level Talents","award":["RLMY-20200001"],"award-info":[{"award-number":["RLMY-20200001"]}]},{"name":"Medical leading Talents Training Program of Yunnan Provincial Health Commission","award":["L-2019026"],"award-info":[{"award-number":["L-2019026"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The morbidity and mortality rates of cardiovascular diseases (CVDs) are increasing; thus, they impose substantial health and economic burdens worldwide, and effective interventions are needed for immediate resolution of this issue. Recent studies have suggested that noncoding RNAs (ncRNAs) play critical roles in the occurrence and development of CVDs and are potential therapeutic targets and novel biomarkers for these diseases. Newly discovered modes of cell death, including necroptosis, pyroptosis, apoptosis, autophagy-dependent cell death and ferroptosis, also play key roles in CVD progression. However, ferroptosis, which differs from the other aforementioned forms of regulated cell death in terms of cell morphology, biochemistry and inhereditability, is a unique iron-dependent mode of nonapoptotic cell death induced by abnormal iron metabolism and excessive accumulation of iron-dependent lipid peroxides and reactive oxygen species (ROS). Increasing evidence has confirmed that ncRNA-mediated ferroptosis is involved in regulating tissue homeostasis and CVD-related pathophysiological conditions, such as cardiac ischemia\/reperfusion (I\/R) injury, myocardial infarction (MI), atrial fibrillation (AF), cardiomyopathy and heart failure (HF). In this review, we summarize the underlying mechanism of ferroptosis, discuss the pathophysiological effects of ncRNA-mediated ferroptosis in CVDs and provide ideas for effective therapeutic strategies.<\/jats:p>","DOI":"10.1007\/s11010-023-04895-w","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T04:02:31Z","timestamp":1702008151000},"page":"2827-2841","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Noncoding RNAs regulating ferroptosis in cardiovascular diseases: novel roles and therapeutic strategies"],"prefix":"10.1007","volume":"479","author":[{"given":"Changyong","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suli","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,8]]},"reference":[{"key":"4895_CR1","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"J Perk","year":"2012","unstructured":"Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R et al (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33:1635\u20131701. https:\/\/doi.org\/10.1093\/eurheartj\/ehs092","journal-title":"Eur Heart J"},{"key":"4895_CR2","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/cir.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y et al (2022) Heart disease and stroke statistics-2022 update: a report from the american heart association. Circulation 145:e153\u2013e639. https:\/\/doi.org\/10.1161\/cir.0000000000001052","journal-title":"Circulation"},{"key":"4895_CR3","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/cir.0000000000000678","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW et al (2019) 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines. Circulation 140:e596\u2013e646. https:\/\/doi.org\/10.1161\/cir.0000000000000678","journal-title":"Circulation"},{"key":"4895_CR4","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","volume":"99","author":"DP Del Re","year":"2019","unstructured":"Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN (2019) Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol Rev 99:1765\u20131817. https:\/\/doi.org\/10.1152\/physrev.00022.2018","journal-title":"Physiol Rev"},{"key":"4895_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/bs.ircmb.2019.11.005","volume":"353","author":"P Patel","year":"2020","unstructured":"Patel P, Karch J (2020) Regulation of cell death in the cardiovascular system. Int Rev Cell Mol Biol 353:153\u2013209. https:\/\/doi.org\/10.1016\/bs.ircmb.2019.11.005","journal-title":"Int Rev Cell Mol Biol"},{"key":"4895_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G (2019) The molecular machinery of regulated cell death. Cell Res 29:347\u2013364. https:\/\/doi.org\/10.1038\/s41422-019-0164-5","journal-title":"Cell Res"},{"key":"4895_CR7","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.cell.2019.04.024","volume":"177","author":"DR Green","year":"2019","unstructured":"Green DR (2019) The coming decade of cell death research: five riddles. Cell 177:1094\u20131107. https:\/\/doi.org\/10.1016\/j.cell.2019.04.024","journal-title":"Cell"},{"key":"4895_CR8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41423-022-00866-1","volume":"19","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang L, Zhou F (2022) Cuproptosis: a new form of programmed cell death. Cell Mol Immunol 19:867\u2013868. https:\/\/doi.org\/10.1038\/s41423-022-00866-1","journal-title":"Cell Mol Immunol"},{"key":"4895_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD et al (2022) Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375:1254\u20131261. https:\/\/doi.org\/10.1126\/science.abf0529","journal-title":"Science"},{"key":"4895_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4103\/1673-5374.346545","volume":"18","author":"WT Yan","year":"2023","unstructured":"Yan WT, Zhao WJ, Hu XM, Ban XX, Ning WY, Wan H, Zhang Q, Xiong K (2023) PANoptosis-like cell death in ischemia\/reperfusion injury of retinal neurons. Neural Regen Res 18:357\u2013363. https:\/\/doi.org\/10.4103\/1673-5374.346545","journal-title":"Neural Regen Res"},{"key":"4895_CR11","doi-asserted-by":"publisher","first-page":"108010","DOI":"10.1016\/j.pharmthera.2021.108010","volume":"232","author":"S Christgen","year":"2022","unstructured":"Christgen S, Tweedell RE, Kanneganti TD (2022) Programming inflammatory cell death for therapy. Pharmacol Ther 232:108010. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108010","journal-title":"Pharmacol Ther"},{"key":"4895_CR12","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"key":"4895_CR13","doi-asserted-by":"publisher","first-page":"813668","DOI":"10.3389\/fcell.2021.813668","volume":"9","author":"Y Leng","year":"2021","unstructured":"Leng Y, Luo X, Yu J, Jia H, Yu B (2021) Ferroptosis: A potential target in cardiovascular disease. Front Cell Dev Biol 9:813668. https:\/\/doi.org\/10.3389\/fcell.2021.813668","journal-title":"Front Cell Dev Biol"},{"key":"4895_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00735-4","author":"X Fang","year":"2022","unstructured":"Fang X, Ardehali H, Min J, Wang F (2022) The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol. https:\/\/doi.org\/10.1038\/s41569-022-00735-4","journal-title":"Nat Rev Cardiol"},{"key":"4895_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.chembiol.2020.03.007","volume":"27","author":"RR Ratan","year":"2020","unstructured":"Ratan RR (2020) The chemical biology of ferroptosis in the central nervous system. Cell Chem Biol 27:479\u2013498. https:\/\/doi.org\/10.1016\/j.chembiol.2020.03.007","journal-title":"Cell Chem Biol"},{"key":"4895_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B (2022) Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer 22:381\u2013396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0","journal-title":"Nat Rev Cancer"},{"key":"4895_CR17","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41419-022-04628-9","volume":"13","author":"L Ni","year":"2022","unstructured":"Ni L, Yuan C, Wu X (2022) Targeting ferroptosis in acute kidney injury. Cell Death Dis 13:182. https:\/\/doi.org\/10.1038\/s41419-022-04628-9","journal-title":"Cell Death Dis"},{"key":"4895_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","volume":"29","author":"J Chen","year":"2022","unstructured":"Chen J, Li X, Ge C, Min J, Wang F (2022) The multifaceted role of ferroptosis in liver disease. Cell Death Differ 29:467\u2013480. https:\/\/doi.org\/10.1038\/s41418-022-00941-0","journal-title":"Cell Death Differ"},{"key":"4895_CR19","doi-asserted-by":"publisher","first-page":"1587922","DOI":"10.1155\/2021\/1587922","volume":"2021","author":"X Li","year":"2021","unstructured":"Li X, Ma N, Xu J, Zhang Y, Yang P, Su X, Xing Y, An N, Yang F, Zhang G et al (2021) Targeting ferroptosis: pathological mechanism and treatment of ischemia-reperfusion injury. Oxid Med Cell Longev 2021:1587922. https:\/\/doi.org\/10.1155\/2021\/1587922","journal-title":"Oxid Med Cell Longev"},{"key":"4895_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10101624","author":"JW Hwang","year":"2021","unstructured":"Hwang JW, Park JH, Park BW, Kim H, Kim JJ, Sim WS, Mishchenko NP, Fedoreyev SA, Vasileva EA, Ban K et al (2021) Histochrome attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis-induced cardiomyocyte death. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox10101624","journal-title":"Antioxidants (Basel)"},{"key":"4895_CR21","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/s1474-4422(16)30246-0","volume":"15","author":"DC Henshall","year":"2016","unstructured":"Henshall DC, Hamer HM, Pasterkamp RJ, Goldstein DB, Kjems J, Prehn JHM, Schorge S, Lamottke K, Rosenow F (2016) MicroRNAs in epilepsy: pathophysiology and clinical utility. Lancet Neurol 15:1368\u20131376. https:\/\/doi.org\/10.1016\/s1474-4422(16)30246-0","journal-title":"Lancet Neurol"},{"key":"4895_CR22","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1152\/physrev.00041.2015","volume":"96","author":"J Beermann","year":"2016","unstructured":"Beermann J, Piccoli MT, Viereck J, Thum T (2016) Non-coding RNAs in development and disease: background, mechanisms, and therapeutic approaches. Physiol Rev 96:1297\u20131325. https:\/\/doi.org\/10.1152\/physrev.00041.2015","journal-title":"Physiol Rev"},{"key":"4895_CR23","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.ygeno.2020.10.024","volume":"113","author":"L Zhu","year":"2021","unstructured":"Zhu L, Li N, Sun L, Zheng D, Shao G (2021) Non-coding RNAs: the key detectors and regulators in cardiovascular disease. Genomics 113:1233\u20131246. https:\/\/doi.org\/10.1016\/j.ygeno.2020.10.024","journal-title":"Genomics"},{"key":"4895_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10741-019-09908-9","volume":"26","author":"F Yousefi","year":"2021","unstructured":"Yousefi F, Soltani BM (2021) Circular RNAs as potential theranostics in the cardiac fibrosis. Heart Fail Rev 26:195\u2013203. https:\/\/doi.org\/10.1007\/s10741-019-09908-9","journal-title":"Heart Fail Rev"},{"key":"4895_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li Z, Huang C, Bao C, Chen L, Lin M, Wang X, Zhong G, Yu B, Hu W, Dai L et al (2015) Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol 22:256\u2013264. https:\/\/doi.org\/10.1038\/nsmb.2959","journal-title":"Nat Struct Mol Biol"},{"key":"4895_CR26","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.molcel.2013.08.017","volume":"51","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Zhang XO, Chen T, Xiang JF, Yin QF, Xing YH, Zhu S, Yang L, Chen LL (2013) Circular intronic long noncoding RNAs. Mol Cell 51:792\u2013806. https:\/\/doi.org\/10.1016\/j.molcel.2013.08.017","journal-title":"Mol Cell"},{"key":"4895_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang X, Ardehali H, Min J, Wang F (2023) The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat Rev Cardiol 20:7\u201323. https:\/\/doi.org\/10.1038\/s41569-022-00735-4","journal-title":"Nat Rev Cardiol"},{"key":"4895_CR28","doi-asserted-by":"publisher","first-page":"114993","DOI":"10.1016\/j.biopha.2023.114993","volume":"164","author":"Y Liu","year":"2023","unstructured":"Liu Y, Ding W, Wang J, Ao X, Xue J (2023) Non-coding RNA-mediated modulation of ferroptosis in cardiovascular diseases. Biomed Pharmacother 164:114993. https:\/\/doi.org\/10.1016\/j.biopha.2023.114993","journal-title":"Biomed Pharmacother"},{"key":"4895_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev-physiol-020518-114742","volume":"81","author":"DM Ward","year":"2019","unstructured":"Ward DM, Cloonan SM (2019) Mitochondrial iron in human health and disease. Annu Rev Physiol 81:453\u2013482. https:\/\/doi.org\/10.1146\/annurev-physiol-020518-114742","journal-title":"Annu Rev Physiol"},{"key":"4895_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217889","author":"T Ravingerov\u00e1","year":"2020","unstructured":"Ravingerov\u00e1 T, Kindernay L, Bartekov\u00e1 M, Ferko M, Adameov\u00e1 A, Zohdi V, Bern\u00e1tov\u00e1 I, Ferenczyov\u00e1 K, Lazou A (2020) The molecular mechanisms of iron metabolism and its role in cardiac dysfunction and cardioprotection. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21217889","journal-title":"Int J Mol Sci"},{"key":"4895_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2018.09.008","volume":"133","author":"DA Stoyanovsky","year":"2019","unstructured":"Stoyanovsky DA, Tyurina YY, Shrivastava I, Bahar I, Tyurin VA, Protchenko O, Jadhav S, Bolevich SB, Kozlov AV, Vladimirov YA et al (2019) Iron catalysis of lipid peroxidation in ferroptosis: regulated enzymatic or random free radical reaction? Free Radic Biol Med 133:153\u2013161. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.09.008","journal-title":"Free Radic Biol Med"},{"key":"4895_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.freeradbiomed.2018.07.018","volume":"133","author":"K Hirota","year":"2019","unstructured":"Hirota K (2019) An intimate crosstalk between iron homeostasis and oxygen metabolism regulated by the hypoxia-inducible factors (HIFs). Free Radic Biol Med 133:118\u2013129. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.07.018","journal-title":"Free Radic Biol Med"},{"key":"4895_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/eurheartj\/ehac569","volume":"44","author":"G Savarese","year":"2023","unstructured":"Savarese G, von Haehling S, Butler J, Cleland JGF, Ponikowski P, Anker SD (2023) Iron deficiency and cardiovascular disease. Eur Heart J 44:14\u201327. https:\/\/doi.org\/10.1093\/eurheartj\/ehac569","journal-title":"Eur Heart J"},{"key":"4895_CR34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1161\/circresaha.122.321667","volume":"132","author":"KT Sawicki","year":"2023","unstructured":"Sawicki KT, De Jesus A, Ardehali H (2023) Iron metabolism in cardiovascular disease: physiology, mechanisms, and therapeutic targets. Circ Res 132:379\u2013396. https:\/\/doi.org\/10.1161\/circresaha.122.321667","journal-title":"Circ Res"},{"key":"4895_CR35","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41586-020-2668-z","volume":"586","author":"CB Billesb\u00f8lle","year":"2020","unstructured":"Billesb\u00f8lle CB, Azumaya CM, Kretsch RC, Powers AS, Gonen S, Schneider S, Arvedson T, Dror RO, Cheng Y, Manglik A (2020) Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms. Nature 586:807\u2013811. https:\/\/doi.org\/10.1038\/s41586-020-2668-z","journal-title":"Nature"},{"key":"4895_CR36","doi-asserted-by":"publisher","first-page":"e13235","DOI":"10.1111\/acel.13235","volume":"19","author":"WD Bao","year":"2020","unstructured":"Bao WD, Zhou XT, Zhou LT, Wang F, Yin X, Lu Y, Zhu LQ, Liu D (2020) Targeting miR-124\/Ferroportin signaling ameliorated neuronal cell death through inhibiting apoptosis and ferroptosis in aged intracerebral hemorrhage murine model. Aging Cell 19:e13235. https:\/\/doi.org\/10.1111\/acel.13235","journal-title":"Aging Cell"},{"key":"4895_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2023.03.006","volume":"201","author":"X Bao","year":"2023","unstructured":"Bao X, Luo X, Bai X, Lv Y, Weng X, Zhang S, Leng Y, Huang J, Dai X, Wang Y et al (2023) Cigarette tar mediates macrophage ferroptosis in atherosclerosis through the hepcidin\/FPN\/SLC7A11 signaling pathway. Free Radic Biol Med 201:76\u201388. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.03.006","journal-title":"Free Radic Biol Med"},{"key":"4895_CR38","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","volume":"32","author":"J Zheng","year":"2020","unstructured":"Zheng J, Conrad M (2020) The metabolic underpinnings of ferroptosis. Cell Metab 32:920\u2013937. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.011","journal-title":"Cell Metab"},{"key":"4895_CR39","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.tibs.2015.11.012","volume":"41","author":"AR Bogdan","year":"2016","unstructured":"Bogdan AR, Miyazawa M, Hashimoto K, Tsuji Y (2016) Regulators of iron homeostasis: new players in metabolism, cell death, and disease. Trends Biochem Sci 41:274\u2013286. https:\/\/doi.org\/10.1016\/j.tibs.2015.11.012","journal-title":"Trends Biochem Sci"},{"key":"4895_CR40","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/cr.2016.95","volume":"26","author":"M Gao","year":"2016","unstructured":"Gao M, Monian P, Pan Q, Zhang W, Xiang J, Jiang X (2016) Ferroptosis is an autophagic cell death process. Cell Res 26:1021\u20131032. https:\/\/doi.org\/10.1038\/cr.2016.95","journal-title":"Cell Res"},{"key":"4895_CR41","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ 3rd, Kang R, Tang D (2016) Autophagy promotes ferroptosis by degradation of ferritin. Autophagy 12:1425\u20131428. https:\/\/doi.org\/10.1080\/15548627.2016.1187366","journal-title":"Autophagy"},{"key":"4895_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2023.03.003","volume":"201","author":"M Zhu","year":"2023","unstructured":"Zhu M, Peng L, Huo S, Peng D, Gou J, Shi W, Tao J, Jiang T, Jiang Y, Wang Q et al (2023) STAT3 signaling promotes cardiac injury by upregulating NCOA4-mediated ferritinophagy and ferroptosis in high-fat-diet fed mice. Free Radic Biol Med 201:111\u2013125. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.03.003","journal-title":"Free Radic Biol Med"},{"key":"4895_CR43","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1038\/onc.2015.32","volume":"34","author":"X Sun","year":"2015","unstructured":"Sun X, Ou Z, Xie M, Kang R, Fan Y, Niu X, Wang H, Cao L, Tang D (2015) HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene 34:5617\u20135625. https:\/\/doi.org\/10.1038\/onc.2015.32","journal-title":"Oncogene"},{"key":"4895_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010442","author":"SW van Wijk","year":"2021","unstructured":"van Wijk SW, Ramos KS, Brundel B (2021) Cardioprotective role of heat shock proteins in atrial fibrillation: From mechanism of action to therapeutic and diagnostic target. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22010442","journal-title":"Int J Mol Sci"},{"key":"4895_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s43018-021-00299-1","volume":"3","author":"T Zhang","year":"2022","unstructured":"Zhang T, Sun L, Hao Y, Suo C, Shen S, Wei H, Ma W, Zhang P, Wang T, Gu X et al (2022) ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1. Nat Cancer 3:75\u201389. https:\/\/doi.org\/10.1038\/s43018-021-00299-1","journal-title":"Nat Cancer"},{"key":"4895_CR46","doi-asserted-by":"publisher","first-page":"e13158","DOI":"10.1111\/cpr.13158","volume":"55","author":"S Yuan","year":"2022","unstructured":"Yuan S, Wei C, Liu G, Zhang L, Li J, Li L, Cai S, Fang L (2022) Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1\u03b1\/SLC7A11 pathway. Cell Prolif 55:e13158. https:\/\/doi.org\/10.1111\/cpr.13158","journal-title":"Cell Prolif"},{"key":"4895_CR47","doi-asserted-by":"publisher","first-page":"112423","DOI":"10.1016\/j.biopha.2021.112423","volume":"145","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Xin L, Xiang M, Shang C, Wang Y, Wang Y, Cui X, Lu Y (2022) The molecular mechanisms of ferroptosis and its role in cardiovascular disease. Biomed Pharmacother 145:112423. https:\/\/doi.org\/10.1016\/j.biopha.2021.112423","journal-title":"Biomed Pharmacother"},{"key":"4895_CR48","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang X, Wang H, Han D, Xie E, Yang X, Wei J, Gu S, Gao F, Zhu N, Yin X et al (2019) Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci USA 116:2672\u20132680. https:\/\/doi.org\/10.1073\/pnas.1821022116","journal-title":"Proc Natl Acad Sci USA"},{"key":"4895_CR49","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41422-019-0150-y","volume":"29","author":"M Conrad","year":"2019","unstructured":"Conrad M, Proneth B (2019) Broken hearts: Iron overload, ferroptosis and cardiomyopathy. Cell Res 29:263\u2013264. https:\/\/doi.org\/10.1038\/s41422-019-0150-y","journal-title":"Cell Res"},{"key":"4895_CR50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.freeradbiomed.2020.08.009","volume":"160","author":"N Li","year":"2020","unstructured":"Li N, Wang W, Zhou H, Wu Q, Duan M, Liu C, Wu H, Deng W, Shen D, Tang Q (2020) Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury. Free Radic Biol Med 160:303\u2013318. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.08.009","journal-title":"Free Radic Biol Med"},{"key":"4895_CR51","doi-asserted-by":"publisher","first-page":"105466","DOI":"10.1016\/j.phrs.2021.105466","volume":"166","author":"N Li","year":"2021","unstructured":"Li N, Jiang W, Wang W, Xiong R, Wu X, Geng Q (2021) Ferroptosis and its emerging roles in cardiovascular diseases. Pharmacol Res 166:105466. https:\/\/doi.org\/10.1016\/j.phrs.2021.105466","journal-title":"Pharmacol Res"},{"key":"4895_CR52","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1172\/jci72931","volume":"124","author":"Y Ichikawa","year":"2014","unstructured":"Ichikawa Y, Ghanefar M, Bayeva M, Wu R, Khechaduri A, Naga Prasad SV, Mutharasan RK, Naik TJ, Ardehali H (2014) Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation. J Clin Invest 124:617\u2013630. https:\/\/doi.org\/10.1172\/jci72931","journal-title":"J Clin Invest"},{"key":"4895_CR53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fphar.2014.00025","volume":"5","author":"E Gammella","year":"2014","unstructured":"Gammella E, Maccarinelli F, Buratti P, Recalcati S, Cairo G (2014) The role of iron in anthracycline cardiotoxicity. Front Pharmacol 5:25. https:\/\/doi.org\/10.3389\/fphar.2014.00025","journal-title":"Front Pharmacol"},{"key":"4895_CR54","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.cellsig.2015.09.003","volume":"27","author":"M Agassandian","year":"2015","unstructured":"Agassandian M, Tedrow JR, Sembrat J, Kass DJ, Zhang Y, Goncharova EA, Kaminski N, Mallampalli RK, Vuga LJ (2015) VCAM-1 is a TGF-\u03b21 inducible gene upregulated in idiopathic pulmonary fibrosis. Cell Signal 27:2467\u20132473. https:\/\/doi.org\/10.1016\/j.cellsig.2015.09.003","journal-title":"Cell Signal"},{"key":"4895_CR55","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1002\/jcp.30780","volume":"237","author":"Z Li","year":"2022","unstructured":"Li Z, Zhu Z, Liu Y, Liu Y, Zhao H (2022) Function and regulation of GPX4 in the development and progression of fibrotic disease. J Cell Physiol 237:2808\u20132824. https:\/\/doi.org\/10.1002\/jcp.30780","journal-title":"J Cell Physiol"},{"key":"4895_CR56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0005-2760(82)90150-3","volume":"710","author":"F Ursini","year":"1982","unstructured":"Ursini F, Maiorino M, Valente M, Ferri L, Gregolin C (1982) Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochim Biophys Acta 710:197\u2013211. https:\/\/doi.org\/10.1016\/0005-2760(82)90150-3","journal-title":"Biochim Biophys Acta"},{"key":"4895_CR57","doi-asserted-by":"publisher","first-page":"34286","DOI":"10.1074\/jbc.M305327200","volume":"278","author":"M Maiorino","year":"2003","unstructured":"Maiorino M, Scapin M, Ursini F, Biasolo M, Bosello V, Floh\u00e9 L (2003) Distinct promoters determine alternative transcription of gpx-4 into phospholipid-hydroperoxide glutathione peroxidase variants. J Biol Chem 278:34286\u201334290. https:\/\/doi.org\/10.1074\/jbc.M305327200","journal-title":"J Biol Chem"},{"key":"4895_CR58","doi-asserted-by":"publisher","first-page":"101824","DOI":"10.1016\/j.jbc.2022.101824","volume":"298","author":"K Azuma","year":"2022","unstructured":"Azuma K, Koumura T, Iwamoto R, Matsuoka M, Terauchi R, Yasuda S, Shiraya T, Watanabe S, Aihara M, Imai H et al (2022) Mitochondrial glutathione peroxidase 4 is indispensable for photoreceptor development and survival in mice. J Biol Chem 298:101824. https:\/\/doi.org\/10.1016\/j.jbc.2022.101824","journal-title":"J Biol Chem"},{"key":"4895_CR59","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41419-020-2618-6","volume":"11","author":"DH Kim","year":"2020","unstructured":"Kim DH, Kim WD, Kim SK, Moon DH, Lee SJ (2020) TGF-\u03b21-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells. Cell Death Dis 11:406. https:\/\/doi.org\/10.1038\/s41419-020-2618-6","journal-title":"Cell Death Dis"},{"key":"4895_CR60","doi-asserted-by":"publisher","first-page":"904314","DOI":"10.3389\/fphar.2022.904314","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Yan J, Zhao Q, Zhang Y, Zhang Y (2022) ATF3 promotes ferroptosis in sorafenib-induced cardiotoxicity by suppressing Slc7a11 expression. Front Pharmacol 13:904314. https:\/\/doi.org\/10.3389\/fphar.2022.904314","journal-title":"Front Pharmacol"},{"key":"4895_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-023-02515-4","author":"M Wang","year":"2023","unstructured":"Wang M, Liu M, Tang L, Shen L, Xiao J, Li R (2023) Liquiritin reduces ferroptosis in doxorubicin-induced cardiotoxicity through targeting SLC7A11\/GPX4 pathway. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-023-02515-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4895_CR62","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1158\/2159-8290.Cd-19-1500","volume":"11","author":"X Hong","year":"2021","unstructured":"Hong X, Roh W, Sullivan RJ, Wong KHK, Wittner BS, Guo H, Dubash TD, Sade-Feldman M, Wesley B, Horwitz E et al (2021) The lipogenic regulator SREBP2 induces transferrin in circulating melanoma cells and suppresses ferroptosis. Cancer Discov 11:678\u2013695. https:\/\/doi.org\/10.1158\/2159-8290.Cd-19-1500","journal-title":"Cancer Discov"},{"key":"4895_CR63","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156:317\u2013331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010","journal-title":"Cell"},{"key":"4895_CR64","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tips.2017.02.005","volume":"38","author":"JPF Angeli","year":"2017","unstructured":"Angeli JPF, Shah R, Pratt DA, Conrad M (2017) Ferroptosis inhibition: mechanisms and opportunities. Trends Pharmacol Sci 38:489\u2013498. https:\/\/doi.org\/10.1016\/j.tips.2017.02.005","journal-title":"Trends Pharmacol Sci"},{"key":"4895_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092167","author":"D Casares","year":"2019","unstructured":"Casares D, Escrib\u00e1 PV, Rossell\u00f3 CA (2019) Membrane lipid composition: Effect on membrane and organelle structure, function and compartmentalization and therapeutic avenues. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20092167","journal-title":"Int J Mol Sci"},{"key":"4895_CR66","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR (2016) Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci USA 113:E4966-4975. https:\/\/doi.org\/10.1073\/pnas.1603244113","journal-title":"Proc Natl Acad Sci USA"},{"key":"4895_CR67","doi-asserted-by":"publisher","first-page":"710963","DOI":"10.3389\/fcvm.2021.710963","volume":"8","author":"H Hu","year":"2021","unstructured":"Hu H, Chen Y, Jing L, Zhai C, Shen L (2021) The link between ferroptosis and cardiovascular diseases: a novel target for treatment. Front Cardiovasc Med 8:710963. https:\/\/doi.org\/10.3389\/fcvm.2021.710963","journal-title":"Front Cardiovasc Med"},{"key":"4895_CR68","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.7150\/thno.54113","volume":"11","author":"X Wu","year":"2021","unstructured":"Wu X, Li Y, Zhang S, Zhou X (2021) Ferroptosis as a novel therapeutic target for cardiovascular disease. Theranostics 11:3052\u20133059. https:\/\/doi.org\/10.7150\/thno.54113","journal-title":"Theranostics"},{"key":"4895_CR69","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1089\/ars.2020.8175","volume":"35","author":"B Hassannia","year":"2021","unstructured":"Hassannia B, Van Coillie S, Vanden Berghe T (2021) Ferroptosis: biological rust of lipid membranes. Antioxid Redox Signal 35:487\u2013509. https:\/\/doi.org\/10.1089\/ars.2020.8175","journal-title":"Antioxid Redox Signal"},{"key":"4895_CR70","doi-asserted-by":"publisher","first-page":"e2006203","DOI":"10.1371\/journal.pbio.2006203","volume":"16","author":"H Feng","year":"2018","unstructured":"Feng H, Stockwell BR (2018) Unsolved mysteries: how does lipid peroxidation cause ferroptosis? PLoS Biol 16:e2006203. https:\/\/doi.org\/10.1371\/journal.pbio.2006203","journal-title":"PLoS Biol"},{"key":"4895_CR71","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41420-022-01183-2","volume":"8","author":"K Wang","year":"2022","unstructured":"Wang K, Chen XZ, Wang YH, Cheng XL, Zhao Y, Zhou LY, Wang K (2022) Emerging roles of ferroptosis in cardiovascular diseases. Cell Death Discov 8:394. https:\/\/doi.org\/10.1038\/s41420-022-01183-2","journal-title":"Cell Death Discov"},{"key":"4895_CR72","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41401-020-0439-x","volume":"42","author":"J Feng","year":"2021","unstructured":"Feng J, Lu PZ, Zhu GZ, Hooi SC, Wu Y, Huang XW, Dai HQ, Chen PH, Li ZJ, Su WJ et al (2021) ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma. Acta Pharmacol Sin 42:160\u2013170. https:\/\/doi.org\/10.1038\/s41401-020-0439-x","journal-title":"Acta Pharmacol Sin"},{"key":"4895_CR73","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A et al (2017) ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol 13:91\u201398. https:\/\/doi.org\/10.1038\/nchembio.2239","journal-title":"Nat Chem Biol"},{"key":"4895_CR74","doi-asserted-by":"publisher","first-page":"154999","DOI":"10.1016\/j.phymed.2023.154999","volume":"119","author":"Q Yu","year":"2023","unstructured":"Yu Q, Zhang N, Gan X, Chen L, Wang R, Liang R, Jian J (2023) EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p\/ACSL4 axis. Phytomedicine 119:154999. https:\/\/doi.org\/10.1016\/j.phymed.2023.154999","journal-title":"Phytomedicine"},{"key":"4895_CR75","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2020.11.024","volume":"81","author":"B Yan","year":"2021","unstructured":"Yan B, Ai Y, Sun Q, Ma Y, Cao Y, Wang J, Zhang Z, Wang X (2021) Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1. Mol Cell 81:355-369.e310. https:\/\/doi.org\/10.1016\/j.molcel.2020.11.024","journal-title":"Mol Cell"},{"key":"4895_CR76","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/acscentsci.7b00589","volume":"4","author":"R Shah","year":"2018","unstructured":"Shah R, Shchepinov MS, Pratt DA (2018) Resolving the role of lipoxygenases in the initiation and execution of ferroptosis. ACS Cent Sci 4:387\u2013396. https:\/\/doi.org\/10.1021\/acscentsci.7b00589","journal-title":"ACS Cent Sci"},{"key":"4895_CR77","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s13238-021-00823-0","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B (2021) Cytochrome P450 reductase (POR) as a ferroptosis fuel. Protein Cell 12:675\u2013679. https:\/\/doi.org\/10.1007\/s13238-021-00823-0","journal-title":"Protein Cell"},{"key":"4895_CR78","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, Mao G, Qu F, Angeli JP, Doll S, Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB et al (2017) Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol 13:81\u201390. https:\/\/doi.org\/10.1038\/nchembio.2238","journal-title":"Nat Chem Biol"},{"key":"4895_CR79","doi-asserted-by":"publisher","first-page":"733229","DOI":"10.3389\/fcvm.2021.733229","volume":"8","author":"Z Chen","year":"2021","unstructured":"Chen Z, Yan Y, Qi C, Liu J, Li L, Wang J (2021) The role of ferroptosis in cardiovascular disease and its therapeutic significance. Front Cardiovasc Med 8:733229. https:\/\/doi.org\/10.3389\/fcvm.2021.733229","journal-title":"Front Cardiovasc Med"},{"key":"4895_CR80","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2019.12.007","volume":"31","author":"MM Santoro","year":"2020","unstructured":"Santoro MM (2020) The antioxidant role of non-mitochondrial CoQ10: mystery solved! Cell Metab 31:13\u201315. https:\/\/doi.org\/10.1016\/j.cmet.2019.12.007","journal-title":"Cell Metab"},{"key":"4895_CR81","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.freeradbiomed.2023.04.024","volume":"204","author":"BJ Dunning","year":"2023","unstructured":"Dunning BJ, Bourgonje AR, Bulthuis MLC, Alexander J, Aaseth JO, Larsson A, van Goor H, Alehagen U (2023) Selenium and coenzyme Q(10) improve the systemic redox status while reducing cardiovascular mortality in elderly population-based individuals. Free Radic Biol Med 204:207\u2013214. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2023.04.024","journal-title":"Free Radic Biol Med"},{"key":"4895_CR82","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1039\/d3fo01255g","volume":"14","author":"E Alarc\u00f3n-Vieco","year":"2023","unstructured":"Alarc\u00f3n-Vieco E, Mart\u00ednez-Garc\u00eda I, Sequ\u00ed-Dom\u00ednguez I, Rodr\u00edguez-Guti\u00e9rrez E, Moreno-Herr\u00e1iz N, Pascual-Morena C (2023) Effect of coenzyme Q10 on cardiac function and survival in heart failure: an overview of systematic reviews and meta-analyses. Food Funct 14:6302\u20136311. https:\/\/doi.org\/10.1039\/d3fo01255g","journal-title":"Food Funct"},{"key":"4895_CR83","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R et al (2019) The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575:688\u2013692. https:\/\/doi.org\/10.1038\/s41586-019-1705-2","journal-title":"Nature"},{"key":"4895_CR84","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva TN, Panzilius E, Scheel CH et al (2019) FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575:693\u2013698. https:\/\/doi.org\/10.1038\/s41586-019-1707-0","journal-title":"Nature"},{"key":"4895_CR85","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41419-022-04660-9","volume":"13","author":"A Jo","year":"2022","unstructured":"Jo A, Bae JH, Yoon YJ, Chung TH, Lee EW, Kim YH, Joh HM, Chung JW (2022) Plasma-activated medium induces ferroptosis by depleting FSP1 in human lung cancer cells. Cell Death Dis 13:212. https:\/\/doi.org\/10.1038\/s41419-022-04660-9","journal-title":"Cell Death Dis"},{"key":"4895_CR86","doi-asserted-by":"publisher","first-page":"964034","DOI":"10.3389\/fcvm.2022.964034","volume":"9","author":"LL Zhang","year":"2022","unstructured":"Zhang LL, Tang RJ, Yang YJ (2022) The underlying pathological mechanism of ferroptosis in the development of cardiovascular disease. Front Cardiovasc Med 9:964034. https:\/\/doi.org\/10.3389\/fcvm.2022.964034","journal-title":"Front Cardiovasc Med"},{"key":"4895_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/cells11172726","author":"LH Xie","year":"2022","unstructured":"Xie LH, Fefelova N, Pamarthi SH, Gwathmey JK (2022) Molecular mechanisms of ferroptosis and relevance to cardiovascular disease. Cells. https:\/\/doi.org\/10.3390\/cells11172726","journal-title":"Cells"},{"key":"4895_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/cells11091399","author":"K Komai","year":"2022","unstructured":"Komai K, Kawasaki NK, Higa JK, Matsui T (2022) The role of ferroptosis in adverse left ventricular remodeling following acute myocardial infarction. Cells. https:\/\/doi.org\/10.3390\/cells11091399","journal-title":"Cells"},{"key":"4895_CR89","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10557-021-07220-z","volume":"36","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zheng C, Gao Z, Chen H, Li K, Wang L, Zheng Y, Li C, Zhang H, Gong M et al (2022) SLC7A11\/xCT prevents cardiac hypertrophy by inhibiting ferroptosis. Cardiovasc Drugs Ther 36:437\u2013447. https:\/\/doi.org\/10.1007\/s10557-021-07220-z","journal-title":"Cardiovasc Drugs Ther"},{"key":"4895_CR90","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1007\/s13577-022-00699-0","volume":"35","author":"MR Valashedi","year":"2022","unstructured":"Valashedi MR, Bamshad C, Najafi-Ghalehlou N, Nikoo A, Tomita K, Kuwahara Y, Sato T, Roushandeh AM, Roudkenar MH (2022) Non-coding RNAs in ferroptotic cancer cell death pathway: meet the new masters. Hum Cell 35:972\u2013994. https:\/\/doi.org\/10.1007\/s13577-022-00699-0","journal-title":"Hum Cell"},{"key":"4895_CR91","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41418-022-00998-x","volume":"29","author":"A Balihodzic","year":"2022","unstructured":"Balihodzic A, Prinz F, Dengler MA, Calin GA, Jost PJ, Pichler M (2022) Non-coding RNAs and ferroptosis: potential implications for cancer therapy. Cell Death Differ 29:1094\u20131106. https:\/\/doi.org\/10.1038\/s41418-022-00998-x","journal-title":"Cell Death Differ"},{"key":"4895_CR92","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jchf.2017.09.015","volume":"6","author":"MC Bahit","year":"2018","unstructured":"Bahit MC, Kochar A, Granger CB (2018) Post-myocardial infarction heart failure. JACC Heart Fail 6:179\u2013186. https:\/\/doi.org\/10.1016\/j.jchf.2017.09.015","journal-title":"JACC Heart Fail"},{"key":"4895_CR93","doi-asserted-by":"publisher","first-page":"9629158","DOI":"10.1155\/2022\/9629158","volume":"2022","author":"Y Zhuang","year":"2022","unstructured":"Zhuang Y, Yang D, Shi S, Wang L, Yu M, Meng X, Fan Y, Zhou R, Wang F (2022) MiR-375-3p promotes cardiac fibrosis by regulating the ferroptosis mediated by GPX4. Comput Intell Neurosci 2022:9629158. https:\/\/doi.org\/10.1155\/2022\/9629158","journal-title":"Comput Intell Neurosci"},{"key":"4895_CR94","doi-asserted-by":"publisher","first-page":"7018393","DOI":"10.1155\/2017\/7018393","volume":"2017","author":"M Neri","year":"2017","unstructured":"Neri M, Riezzo I, Pascale N, Pomara C, Turillazzi E (2017) Ischemia\/Reperfusion injury following acute myocardial infarction: a critical issue for clinicians and forensic pathologists. Mediators Inflamm 2017:7018393. https:\/\/doi.org\/10.1155\/2017\/7018393","journal-title":"Mediators Inflamm"},{"key":"4895_CR95","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.7150\/thno.73931","volume":"12","author":"DM Hermann","year":"2022","unstructured":"Hermann DM, Xin W, B\u00e4hr M, Giebel B, Doeppner TR (2022) Emerging roles of extracellular vesicle-associated non-coding RNAs in hypoxia: Insights from cancer, myocardial infarction and ischemic stroke. Theranostics 12:5776\u20135802. https:\/\/doi.org\/10.7150\/thno.73931","journal-title":"Theranostics"},{"key":"4895_CR96","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.18632\/aging.203997","volume":"14","author":"X Wang","year":"2022","unstructured":"Wang X, Liu Y, Hou H, Shao W, Huang D, Hao Z, Xue H, Ye Y (2022) MiRNA-29 aggravates myocardial infarction via inhibiting the PI3K\/mTOR\/HIF1\u03b1\/VEGF pathway. Aging (Albany NY) 14:3129\u20133142. https:\/\/doi.org\/10.18632\/aging.203997","journal-title":"Aging (Albany NY)"},{"key":"4895_CR97","doi-asserted-by":"publisher","first-page":"174403","DOI":"10.1016\/j.ejphar.2021.174403","volume":"909","author":"K Fan","year":"2021","unstructured":"Fan K, Huang W, Qi H, Song C, He C, Liu Y, Zhang Q, Wang L, Sun H (2021) The Egr-1\/miR-15a-5p\/GPX4 axis regulates ferroptosis in acute myocardial infarction. Eur J Pharmacol 909:174403. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174403","journal-title":"Eur J Pharmacol"},{"key":"4895_CR98","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10565-020-09530-8","volume":"37","author":"Y Song","year":"2021","unstructured":"Song Y, Wang B, Zhu X, Hu J, Sun J, Xuan J, Ge Z (2021) Human umbilical cord blood-derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice. Cell Biol Toxicol 37:51\u201364. https:\/\/doi.org\/10.1007\/s10565-020-09530-8","journal-title":"Cell Biol Toxicol"},{"key":"4895_CR99","doi-asserted-by":"publisher","DOI":"10.23736\/s0031-0808.20.03979-8","author":"S Tang","year":"2020","unstructured":"Tang S, Wang Y, Ma T, Lu S, Huang K, Li Q, Wu M, Yang H, Zhong J (2020) MiR-30d inhibits cardiomyocytes autophagy promoting ferroptosis after myocardial infarction. Panminerva Med. https:\/\/doi.org\/10.23736\/s0031-0808.20.03979-8","journal-title":"Panminerva Med"},{"key":"4895_CR100","doi-asserted-by":"publisher","first-page":"104645","DOI":"10.1016\/j.yexmp.2021.104645","volume":"121","author":"G Li","year":"2021","unstructured":"Li G, Jin J, Liu S, Ding K, Qian C (2021) Inhibition of miR-1224 suppresses hypoxia\/reoxygenation-induced oxidative stress and apoptosis in cardiomyocytes through targeting GPX4. Exp Mol Pathol 121:104645. https:\/\/doi.org\/10.1016\/j.yexmp.2021.104645","journal-title":"Exp Mol Pathol"},{"key":"4895_CR101","doi-asserted-by":"publisher","first-page":"663832","DOI":"10.3389\/fcvm.2021.663832","volume":"8","author":"W Sun","year":"2021","unstructured":"Sun W, Shi R, Guo J, Wang H, Shen L, Shi H, Yu P, Chen X (2021) MiR-135b-3p promotes cardiomyocyte ferroptosis by targeting GPX4 and aggravates myocardial ischemia\/reperfusion injury. Front Cardiovasc Med 8:663832. https:\/\/doi.org\/10.3389\/fcvm.2021.663832","journal-title":"Front Cardiovasc Med"},{"key":"4895_CR102","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10616-020-00446-z","volume":"73","author":"D He","year":"2021","unstructured":"He D, Yan L (2021) MiR-29b-3p aggravates cardiac hypoxia\/reoxygenation injury via targeting PTX3. Cytotechnology 73:91\u2013100. https:\/\/doi.org\/10.1007\/s10616-020-00446-z","journal-title":"Cytotechnology"},{"key":"4895_CR103","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbrc.2021.05.100","volume":"566","author":"X Zhou","year":"2021","unstructured":"Zhou X, Zhuo M, Zhang Y, Shi E, Ma X, Li H (2021) MiR-190a-5p regulates cardiomyocytes response to ferroptosis via directly targeting GLS2. Biochem Biophys Res Commun 566:9\u201315. https:\/\/doi.org\/10.1016\/j.bbrc.2021.05.100","journal-title":"Biochem Biophys Res Commun"},{"key":"4895_CR104","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/kjm2.12605","volume":"38","author":"GY Zhang","year":"2022","unstructured":"Zhang GY, Gao Y, Guo XY, Wang GH, Guo CX (2022) MiR-199a-5p promotes ferroptosis-induced cardiomyocyte death responding to oxygen-glucose deprivation\/reperfusion injury via inhibiting Akt\/eNOS signaling pathway. Kaohsiung J Med Sci 38:1093\u20131102. https:\/\/doi.org\/10.1002\/kjm2.12605","journal-title":"Kaohsiung J Med Sci"},{"key":"4895_CR105","doi-asserted-by":"publisher","first-page":"102618","DOI":"10.1016\/j.nano.2022.102618","volume":"47","author":"JJ Ji","year":"2022","unstructured":"Ji JJ, Chen SY, Yang ZW, Zhang R, Qian LL, Jiang Y, Guo JQ, Wu Y, Fan QL, Yao YY et al (2022) Delivery of Mir-196c-3p with NIR-II light-triggered gel attenuates cardiomyocyte ferroptosis in cardiac ischemia-reperfusion injury. Nanomedicine 47:102618. https:\/\/doi.org\/10.1016\/j.nano.2022.102618","journal-title":"Nanomedicine"},{"key":"4895_CR106","doi-asserted-by":"publisher","first-page":"101956","DOI":"10.1016\/j.tice.2022.101956","volume":"79","author":"D Lei","year":"2022","unstructured":"Lei D, Li B, Isa Z, Ma X, Zhang B (2022) Hypoxia-elicited cardiac microvascular endothelial cell-derived exosomal miR-210-3p alleviate hypoxia\/reoxygenation-induced myocardial cell injury through inhibiting transferrin receptor 1-mediated ferroptosis. Tissue Cell 79:101956. https:\/\/doi.org\/10.1016\/j.tice.2022.101956","journal-title":"Tissue Cell"},{"key":"4895_CR107","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41419-020-02777-3","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang J, Deng B, Liu Q, Huang Y, Chen W, Li J, Zhou Z, Zhang L, Liang B, He J et al (2020) Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload. Cell Death Dis 11:574. https:\/\/doi.org\/10.1038\/s41419-020-02777-3","journal-title":"Cell Death Dis"},{"key":"4895_CR108","doi-asserted-by":"publisher","first-page":"e10692","DOI":"10.1590\/1414-431x202010692","volume":"54","author":"J Xiao","year":"2021","unstructured":"Xiao J, Zhang Y, Tang Y, Dai H, OuYang Y, Li C, Yu M (2021) Hsa-miR-4443 inhibits myocardial fibroblast proliferation by targeting THBS1 to regulate TGF-\u03b21\/\u03b1-SMA\/collagen signaling in atrial fibrillation. Braz J Med Biol Res 54:e10692. https:\/\/doi.org\/10.1590\/1414-431x202010692","journal-title":"Braz J Med Biol Res"},{"key":"4895_CR109","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10863-022-09934-7","volume":"54","author":"X Han","year":"2022","unstructured":"Han X, Wang S, Yong Z, Zhang X, Wang X (2022) MiR-29b ameliorates atrial fibrosis in rats with atrial fibrillation by targeting TGF\u03b2R\u0399 and inhibiting the activation of Smad-2\/3 pathway. J Bioenerg Biomembr 54:81\u201391. https:\/\/doi.org\/10.1007\/s10863-022-09934-7","journal-title":"J Bioenerg Biomembr"},{"key":"4895_CR110","doi-asserted-by":"publisher","first-page":"122","DOI":"10.14348\/molcells.2021.0066","volume":"45","author":"F Guo","year":"2022","unstructured":"Guo F, Tang C, Huang B, Gu L, Zhou J, Mo Z, Liu C, Liu Y (2022) LncRNA H19 drives proliferation of cardiac fibroblasts and collagen production via suppression of the miR-29a-3p\/miR-29b-3p-VEGFA\/TGF-\u03b2 Axis. Mol Cells 45:122\u2013133. https:\/\/doi.org\/10.14348\/molcells.2021.0066","journal-title":"Mol Cells"},{"key":"4895_CR111","doi-asserted-by":"publisher","first-page":"3961495","DOI":"10.1155\/2022\/3961495","volume":"2022","author":"D Liu","year":"2022","unstructured":"Liu D, Yang M, Yao Y, He S, Wang Y, Cao Z, Chen H, Fu Y, Liu H, Zhao Q (2022) Cardiac fibroblasts promote ferroptosis in atrial fibrillation by secreting exo-miR-23a-3p targeting SLC7A11. Oxid Med Cell Longev 2022:3961495. https:\/\/doi.org\/10.1155\/2022\/3961495","journal-title":"Oxid Med Cell Longev"},{"key":"4895_CR112","doi-asserted-by":"publisher","first-page":"733","DOI":"10.32604\/biocell.2021.013236","volume":"45","author":"Y Song","year":"2021","unstructured":"Song Y, Wei CAI, Wang J (2021) Upregulation of miR-143\u20133p attenuates oxidative stress-mediated cell ferroptosis in cardiomyocytes with atrial fibrillation by degrading glutamic-oxaloacetic transaminase 1. Biocell 45:733\u2013744. https:\/\/doi.org\/10.32604\/biocell.2021.013236","journal-title":"Biocell"},{"key":"4895_CR113","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.ymthe.2020.10.024","volume":"29","author":"C Song","year":"2021","unstructured":"Song C, Qi H, Liu Y, Chen Y, Shi P, Zhang S, Ren J, Wang L, Cao Y, Sun H (2021) Inhibition of lncRNA Gm15834 attenuates autophagy-mediated myocardial hypertrophy via the miR-30b-3p\/ULK1 axis in mice. Mol Ther 29:1120\u20131137. https:\/\/doi.org\/10.1016\/j.ymthe.2020.10.024","journal-title":"Mol Ther"},{"key":"4895_CR114","doi-asserted-by":"publisher","first-page":"672391","DOI":"10.3389\/fcell.2022.672391","volume":"10","author":"W Sun","year":"2022","unstructured":"Sun W, Wu X, Yu P, Zhang Q, Shen L, Chen J, Tong H, Fan M, Shi H, Chen X (2022) LncAABR07025387.1 enhances myocardial ischemia\/reperfusion injury via miR-205\/ACSL4-mediated ferroptosis. Front Cell Dev Biol 10:672391. https:\/\/doi.org\/10.3389\/fcell.2022.672391","journal-title":"Front Cell Dev Biol"},{"key":"4895_CR115","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.numecd.2021.10.017","volume":"32","author":"JK Zhang","year":"2022","unstructured":"Zhang JK, Zhang Z, Guo ZA, Fu Y, Chen XJ, Chen WJ, Wu HF, Cui XJ (2022) The BMSC-derived exosomal lncRNA Mir9-3hg suppresses cardiomyocyte ferroptosis in ischemia-reperfusion mice via the Pum2\/PRDX6 axis. Nutr Metab Cardiovasc Dis 32:515\u2013527. https:\/\/doi.org\/10.1016\/j.numecd.2021.10.017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"4895_CR116","doi-asserted-by":"publisher","first-page":"10786","DOI":"10.1080\/21655979.2022.2065743","volume":"13","author":"F Gao","year":"2022","unstructured":"Gao F, Zhao Y, Zhang B, Xiao C, Sun Z, Gao Y, Dou X (2022) Suppression of lncRNA Gm47283 attenuates myocardial infarction via miR-706\/ Ptgs2\/ferroptosis axis. Bioengineered 13:10786\u201310802. https:\/\/doi.org\/10.1080\/21655979.2022.2065743","journal-title":"Bioengineered"},{"key":"4895_CR117","doi-asserted-by":"publisher","first-page":"9995","DOI":"10.1111\/jcmm.16890","volume":"25","author":"T Ni","year":"2021","unstructured":"Ni T, Huang X, Pan S, Lu Z (2021) Inhibition of the long non-coding RNA ZFAS1 attenuates ferroptosis by sponging miR-150-5p and activates CCND2 against diabetic cardiomyopathy. J Cell Mol Med 25:9995\u201310007. https:\/\/doi.org\/10.1111\/jcmm.16890","journal-title":"J Cell Mol Med"},{"key":"4895_CR118","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.jfma.2020.11.004","volume":"120","author":"J Li","year":"2021","unstructured":"Li J, Zhang Q, Jiao H (2021) LncRNA NRON promotes M2 macrophage polarization and alleviates atrial fibrosis through suppressing exosomal miR-23a derived from atrial myocytes. J Formos Med Assoc 120:1512\u20131519. https:\/\/doi.org\/10.1016\/j.jfma.2020.11.004","journal-title":"J Formos Med Assoc"},{"key":"4895_CR119","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1002\/cbin.11707","volume":"45","author":"S Zhang","year":"2021","unstructured":"Zhang S, Wang N, Ma Q, Fan F, Ma X (2021) LncRNA TUG1 acts as a competing endogenous RNA to mediate CTGF expression by sponging miR-133b in myocardial fibrosis after myocardial infarction. Cell Biol Int 45:2534\u20132543. https:\/\/doi.org\/10.1002\/cbin.11707","journal-title":"Cell Biol Int"},{"key":"4895_CR120","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.omtn.2021.10.024","volume":"27","author":"P Shi","year":"2022","unstructured":"Shi P, Li M, Song C, Qi H, Ba L, Cao Y, Zhang M, Xie Y, Ren J, Wu J et al (2022) Neutrophil-like cell membrane-coated siRNA of lncRNA AABR07017145.1 therapy for cardiac hypertrophy via inhibiting ferroptosis of CMECs. Mol Ther Nucleic Acids 27:16\u201336. https:\/\/doi.org\/10.1016\/j.omtn.2021.10.024","journal-title":"Mol Ther Nucleic Acids"},{"key":"4895_CR121","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-021-09660-7","author":"S Zhuang","year":"2021","unstructured":"Zhuang S, Ma Y, Zeng Y, Lu C, Yang F, Jiang N, Ge J, Ju H, Zhong C, Wang J et al (2021) METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis. Cell Biol Toxicol. https:\/\/doi.org\/10.1007\/s10565-021-09660-7","journal-title":"Cell Biol Toxicol"},{"key":"4895_CR122","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/cvr\/cvaa302","volume":"118","author":"R Jayaram","year":"2022","unstructured":"Jayaram R, Jones M, Reilly S, Crabtree MJ, Pal N, Goodfellow N, Nahar K, Simon J, Carnicer R, DeSilva R et al (2022) Atrial nitroso-redox balance and refractoriness following on-pump cardiac surgery: a randomized trial of atorvastatin. Cardiovasc Res 118:184\u2013195. https:\/\/doi.org\/10.1093\/cvr\/cvaa302","journal-title":"Cardiovasc Res"},{"key":"4895_CR123","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1111\/ajt.16475","volume":"21","author":"Y Su","year":"2021","unstructured":"Su Y, Zhu C, Wang B, Zheng H, McAlister V, Lacefield JC, Quan D, Mele T, Greasley A, Liu K et al (2021) Circular RNA Foxo3 in cardiac ischemia-reperfusion injury in heart transplantation: a new regulator and target. Am J Transplant 21:2992\u20133004. https:\/\/doi.org\/10.1111\/ajt.16475","journal-title":"Am J Transplant"},{"key":"4895_CR124","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.healun.2021.03.025","volume":"40","author":"B Wang","year":"2021","unstructured":"Wang B, Zhou Q, Li A, Li S, Greasley A, Skaro A, Quan D, Min W, Liu K, Zheng X (2021) Preventing alloimmune rejection using circular RNA FSCN1-silenced dendritic cells in heart transplantation. J Heart Lung Transplant 40:584\u2013594. https:\/\/doi.org\/10.1016\/j.healun.2021.03.025","journal-title":"J Heart Lung Transplant"},{"key":"4895_CR125","doi-asserted-by":"publisher","DOI":"10.1097\/crd.0000000000000393","author":"R Nog","year":"2021","unstructured":"Nog R, Gupta CA, Panza JA (2021) Role of micro RNA in heart transplant. Cardiol Rev. https:\/\/doi.org\/10.1097\/crd.0000000000000393","journal-title":"Cardiol Rev"},{"key":"4895_CR126","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s11658-022-00395-9","volume":"27","author":"T Wu","year":"2022","unstructured":"Wu T, Shi G, Ji Z, Wang S, Geng L, Guo Z (2022) Circulating small extracellular vesicle-encapsulated SEMA5A-IT1 attenuates myocardial ischemia-reperfusion injury after cardiac surgery with cardiopulmonary bypass. Cell Mol Biol Lett 27:95. https:\/\/doi.org\/10.1186\/s11658-022-00395-9","journal-title":"Cell Mol Biol Lett"},{"key":"4895_CR127","doi-asserted-by":"publisher","first-page":"8963987","DOI":"10.1155\/2021\/8963987","volume":"2021","author":"RL Li","year":"2021","unstructured":"Li RL, Fan CH, Gong SY, Kang S (2021) Effect and mechanism of LRP6 on cardiac myocyte ferroptosis in myocardial infarction. Oxid Med Cell Longev 2021:8963987. https:\/\/doi.org\/10.1155\/2021\/8963987","journal-title":"Oxid Med Cell Longev"},{"key":"4895_CR128","doi-asserted-by":"publisher","first-page":"656093","DOI":"10.3389\/fcvm.2021.656093","volume":"8","author":"H Zheng","year":"2021","unstructured":"Zheng H, Shi L, Tong C, Liu Y, Hou M (2021) CircSnx12 Is involved in ferroptosis during heart failure by targeting miR-224-5p. Front Cardiovasc Med 8:656093. https:\/\/doi.org\/10.3389\/fcvm.2021.656093","journal-title":"Front Cardiovasc Med"},{"key":"4895_CR129","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12929-023-00927-1","volume":"30","author":"J Ju","year":"2023","unstructured":"Ju J, Li XM, Zhao XM, Li FH, Wang SC, Wang K, Li RF, Zhou LY, Liang L, Wang Y et al (2023) Circular RNA FEACR inhibits ferroptosis and alleviates myocardial ischemia\/reperfusion injury by interacting with NAMPT. J Biomed Sci 30:45. https:\/\/doi.org\/10.1186\/s12929-023-00927-1","journal-title":"J Biomed Sci"},{"key":"4895_CR130","doi-asserted-by":"publisher","first-page":"121873","DOI":"10.1016\/j.lfs.2023.121873","volume":"328","author":"QR Xu","year":"2023","unstructured":"Xu QR, Liu JL, Zhu RR, Huang WX, Huang H, Liu JC, Xu XP, Zhou XL (2023) NSD2 promotes pressure overload-induced cardiac hypertrophy via activating circCmiss1\/TfR1\/ferroptosis signaling. Life Sci 328:121873. https:\/\/doi.org\/10.1016\/j.lfs.2023.121873","journal-title":"Life Sci"},{"key":"4895_CR131","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cca.2021.03.010","volume":"518","author":"B Liu","year":"2021","unstructured":"Liu B, Zhao N, Zhou Y, Lu Y, Chen W, Huang Z, Wang D, Xu Y, Wai Ping Yam J, Cui Y (2021) Circular RNA circ_ABCB10 in cancer. Clin Chim Acta 518:93\u2013100. https:\/\/doi.org\/10.1016\/j.cca.2021.03.010","journal-title":"Clin Chim Acta"},{"key":"4895_CR132","doi-asserted-by":"publisher","first-page":"627","DOI":"10.7150\/thno.22177","volume":"8","author":"Z Chen","year":"2018","unstructured":"Chen Z, Li Y, Wang Y, Qian J, Ma H, Wang X, Jiang G, Liu M, An Y, Ma L et al (2018) Cardiomyocyte-restricted low density lipoprotein receptor-related protein 6 (LRP6) deletion leads to lethal dilated cardiomyopathy partly through Drp1 signaling. Theranostics 8:627\u2013643. https:\/\/doi.org\/10.7150\/thno.22177","journal-title":"Theranostics"},{"key":"4895_CR133","doi-asserted-by":"publisher","first-page":"1173040","DOI":"10.3389\/fphar.2023.1173040","volume":"14","author":"F Li","year":"2023","unstructured":"Li F, Li PF, Hao XD (2023) Circular RNAs in ferroptosis: Regulation mechanism and potential clinical application in disease. Front Pharmacol 14:1173040. https:\/\/doi.org\/10.3389\/fphar.2023.1173040","journal-title":"Front Pharmacol"},{"key":"4895_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202300379","author":"F Zeng","year":"2023","unstructured":"Zeng F, Nijiati S, Tang L, Ye J, Zhou Z, Chen X (2023) Ferroptosis detection: from approaches to applications. Angew Chem Int Ed Engl. https:\/\/doi.org\/10.1002\/anie.202300379","journal-title":"Angew Chem Int Ed Engl"},{"key":"4895_CR135","doi-asserted-by":"publisher","first-page":"e202115572","DOI":"10.1002\/anie.202115572","volume":"61","author":"N Chen","year":"2022","unstructured":"Chen N, Du N, Wang W, Liu T, Yuan Q, Yang Y (2022) Real-time monitoring of dynamic microbial Fe(III) respiration metabolism with a living cell-compatible electron-sensing probe. Angew Chem Int Ed Engl 61:e202115572. https:\/\/doi.org\/10.1002\/anie.202115572","journal-title":"Angew Chem Int Ed Engl"},{"key":"4895_CR136","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-0716-0247-8_11","volume":"2108","author":"AM Martinez","year":"2020","unstructured":"Martinez AM, Kim A, Yang WS (2020) Detection of ferroptosis by BODIPY\u2122 581\/591 C11. Methods Mol Biol 2108:125\u2013130. https:\/\/doi.org\/10.1007\/978-1-0716-0247-8_11","journal-title":"Methods Mol Biol"},{"key":"4895_CR137","doi-asserted-by":"publisher","first-page":"eadd8539","DOI":"10.1126\/sciadv.add8539","volume":"9","author":"F Zeng","year":"2023","unstructured":"Zeng F, Nijiati S, Liu Y, Yang Q, Liu X, Zhang Q, Chen S, Su A, Xiong H, Shi C et al (2023) Ferroptosis MRI for early detection of anticancer drug-induced acute cardiac\/kidney injuries. Sci Adv 9:eadd8539. https:\/\/doi.org\/10.1126\/sciadv.add8539","journal-title":"Sci Adv"},{"key":"4895_CR138","doi-asserted-by":"publisher","unstructured":"Zhou N, Bao J (2020) FerrDb: A manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database (Oxford) 2020: https:\/\/doi.org\/10.1093\/database\/baaa021","DOI":"10.1093\/database\/baaa021"},{"key":"4895_CR139","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac935","author":"N Zhou","year":"2022","unstructured":"Zhou N, Yuan X, Du Q, Zhang Z, Shi X, Bao J, Ning Y, Peng L (2022) FerrDb V2: Update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkac935","journal-title":"Nucleic Acids Res"},{"key":"4895_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpb.2022.09.004","author":"S Zhou","year":"2022","unstructured":"Zhou S, Huang YE, Xing J, Zhou X, Chen S, Chen J, Wang L, Jiang W (2022) NcFO: a comprehensive resource of curated and predicted ncRNAs associated with ferroptosis. Genom Proteom Bioinform. https:\/\/doi.org\/10.1016\/j.gpb.2022.09.004","journal-title":"Genom Proteom Bioinform"},{"key":"4895_CR141","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrcardio.2014.125","volume":"11","author":"T Thum","year":"2014","unstructured":"Thum T (2014) Noncoding RNAs and myocardial fibrosis. Nat Rev Cardiol 11:655\u2013663. https:\/\/doi.org\/10.1038\/nrcardio.2014.125","journal-title":"Nat Rev Cardiol"},{"key":"4895_CR142","doi-asserted-by":"publisher","first-page":"937995","DOI":"10.3389\/fcvm.2022.937995","volume":"9","author":"Y Dong","year":"2022","unstructured":"Dong Y, Peng N, Dong L, Tan S, Zhang X (2022) Non-coding RNAs: important participants in cardiac fibrosis. Front Cardiovasc Med 9:937995. https:\/\/doi.org\/10.3389\/fcvm.2022.937995","journal-title":"Front Cardiovasc Med"},{"key":"4895_CR143","doi-asserted-by":"publisher","first-page":"5295434","DOI":"10.1155\/2022\/5295434","volume":"2022","author":"X Du","year":"2022","unstructured":"Du X, Dong R, Wu Y, Ni B (2022) Physiological effects of ferroptosis on organ fibrosis. Oxid Med Cell Longev 2022:5295434. https:\/\/doi.org\/10.1155\/2022\/5295434","journal-title":"Oxid Med Cell Longev"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04895-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-023-04895-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04895-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T17:02:09Z","timestamp":1728925329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-023-04895-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,8]]},"references-count":143,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["4895"],"URL":"https:\/\/doi.org\/10.1007\/s11010-023-04895-w","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,8]]},"assertion":[{"value":"30 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}